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Objective: To assess the association of perioperative cardiac dysfunction during elective vascular surgery with postopera-
tive outcome.
Background: Patients with normal systolic function can have isolated diastolic dysfunction. Routine preoperative
evaluation of left ventricular (LV) function does not include an assessment of diastolic function for risk stratification. We
hypothesized that perioperative assessment of both diastolic and systolic function with transesophageal echo (TEE) may
improve our ability to predict postoperative outcome.
Methods: Perioperative TEE examinations were carried out on patients undergoing elective vascular surgery under general
anesthesia. Abnormal systolic function was defined as LV ejection fraction (LVEF) <40%. Left ventricular diastolic
function was assessed using transmitral flow propagation velocity (Vp); Vp <45 cm/sec was considered abnormal. We
determined the association between LV function and the primary outcome of postoperative adverse outcome, defined as
one or more adverse events: myocardial infarction (MI), congestive heart failure (CHF), significant arrhythmia,
prolonged intubation, renal failure, and death.
Results:Three hundred thirteen patients undergoing vascular surgery were studied.We found that 8% (n 24) of patients
had isolated systolic dysfunction, 43% (n  134) had isolated diastolic dysfunction, and 24% (n  75) both systolic and
diastolic dysfunction. The most common postoperative adverse outcome was CHF 20% (n 62). By multivariate logistic
regression, we found that patient age, Vp, type of surgery, female gender, and renal failure were predictive of
postoperative adverse outcome.
Conclusion: The presence of perioperative diastolic dysfunction as assessed with Vp is an independent predictor of
postoperative CHF and prolonged length of stay after major vascular surgery. Patient age, gender, type of surgery, and
renal failure were also predictors of outcome. Perioperative systolic function was not a predictor of postoperative outcome
in our patients. ( J Vasc Surg 2009;50:70-6.)A history of congestive heart failure (CHF) significantly
increases the risk of postoperative morbidity and mortality
after non-cardiac surgery.1-3 CHF is a clinical diagnosis that
can be due to both systolic and diastolic ventricular dys-
function; whether patients with history of CHF should be
treated differently based on their specific cardiac dysfunc-
tion is not known, and preoperative risk assessment in
non-cardiac surgery has thus far been limited to the evalu-
ation to ventricular systolic function or wall motion abnor-
malities.4-7 However, when evaluated in conjunction with
other clinical risk factors, left ventricular systolic function
has not been found to add significant predictive value of
postoperative cardiac complications.4 On the other hand,
the evaluation of diastolic function as a characteristic that
may exert an independent effect on postoperative morbid-
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70ity has thus far been limited. Further, assessment of diastolic
function prior to surgery is not routinely performed.8-11 We
hypothesized that independently examining both systolic and
diastolic ventricular function using transesophageal echocar-
diography (TEE) during high-risk vascular surgery may im-
prove our ability to predict postoperative adverse outcome.
METHODS
After obtaining institutional review board approval,
consecutive patients undergoing elective vascular surgery
under general anesthesia (GA) between January 2005 and
December 2007 were evaluated for participation in this
prospective observational study. The exclusion criteria were
emergency surgery, surgery under regional anesthesia, se-
vere valvular disorders (severe aortic/mitral stenosis or
regurgitation),12,13 or contraindications to TEE.
Intraoperative care. Patient received continuous in-
traoperative monitoring with intra-arterial blood pressure,
central venous pressure, pulse oximetry, electrocardiogra-
phy, inspired oxygen, and expired carbon dioxide tension.
Induction of GA was standardized with propofol (2.0
mg/kg) or etomidate (0.3 mg/kg) if LV ejection fraction
(LVEF) was known to be 45% for induction. Anesthesia
was maintained with 0.5%-0.75% inspired isoflurane in a
50% nitrous oxide and oxygen mixture. Muscle relaxation
was initiated using succinylcholine (1.5 mg/kg) and main-
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Surgical analgesia was provided with intravenous fentanyl,
dose of which was determined by the anesthesiologist, and
intravenous morphine for pain relief postoperatively.
Tachycardia, defined as a sustained heart rate greater than
90 beats/minute, was treated with either metoprolol or
esmolol, with the selection based on the clinical situation.
All patients were planned to be extubated at the conclusion
of the procedure using standardized criteria. Patients who
failed to meet the criteria for extubation at the end of the
procedure were ventilated in a monitored recovery unit.
A TEE probe was inserted after induction of GA, and a
comprehensive TEE examination was carried out by study
investigators (FM, RM, BS, PP, JM) who were certified in
perioperative TEE by the National Board of Echocardiog-
raphy. All the studies were performed with Philips IE33 or
SONOS 5500 ultrasound system (Phillips Medical Sys-
tems, Andover, Mass) with Omniplane II probes. Studies
were recorded digitally in Digital Imaging for Communi-
cation in Medicine format and later reviewed on the Echo
Picture Archiving and Communication System station (GE
Medical Systems, Waukesha, Wisc) for accuracy. The TEE
probe was kept in situ for the duration of the surgical
procedure.
Assessment of systolic function. Systolic function
was assessed with a visual quantitative estimation (VQE) of
left ventricular ejection fraction (LVEF) in the transgastric
short axis view. The wall motion abnormalities were re-
corded in multiple mid-esophageal and transgastric views
of the left ventricle.14,15 An LVEF of 40% was catego-
rized as abnormal. The VQE method of LVEF assessment
has shown excellent correlation with radionuclide-derived
LVEF (r  0.967; P  .001) and provides highly compa-
rable results to the invasively derived EF assessment with
experience.16,17
Assessment of diastolic function. Assessment of dia-
stolic function was performed by measuring the transmitral
flow propagation velocity (Vp) using described methodo-
logy.18,19 Briefly, with the TEE probe in the mid-esophageal
four chamber view, and ensuring parallel alignment of the
Doppler beam and adjustment of the Nyquist limit to
obtain a clear wave front of flow propagation, the color flow
box was positioned on the LV cavity. The slope of the first
aliasing velocity was followed from the mitral valve opening
to 4 cm into the LV cavity. A Vp value of0.45 m/sec was
considered consistent with diastolic dysfunction (Fig 1).
Measurement of Vp has also shown excellent reproducibil-
ity ( 0.96) and intra and inter-observer variability (2.0
1.1% mean and 2.2  1.4% mean, respectively).20,21
Postoperative care. After discharge from the post-
anesthesia recovery unit (PACU) the patients were admit-
ted to the vascular surgery intensive care unit (VICU). All
patients had a 12-lead electrocardiogram (EKG) on arrival
in the PACU and every six hours for the next 48 hours.
Troponin-T levels were measured on patients postopera-
tively who experienced anginal symptoms with or without
hemodynamic instability, ST segment changes, left bundle
branch block, or new Q waves on EKG. A portable chestX-ray was obtained on arrival in the PACU and further films
were obtained as indicated by the clinical situation. The
following adverse events were identified: myocardial infarc-
tion (MI), CHF, significant arrhythmia, prolonged intuba-
tion, renal failure, and death. Events were defined as:
1. MI: Troponin-T level 0.01 ng/ml or Creatine
Phosphokinase-MB (CPK-MB) elevationor newQwaves
in two adjacent leads.
2. CHF: Clinical AND radiological evidence of pulmonary
edema that required diuresis AND supplemental oxygen
by facemask or endotrachaeal intubation.
3. Significant arrhythmias: New onset brady- or tachy-
arrhythmias associated with hemodynamic changes re-
quiring medications or electrical cardioversion.
4. Renal failure: Increase in creatinine concentration of2
gm/dl, or new requirement of postoperative hemodial-
ysis.
5. Requirement for postoperative intubation of greater
than 24 hours was categorized as prolonged intubation.
Statistical analysis. We analyzed the relationship be-
tween adverse events and TEE measures of left ventricular
systolic and diastolic function (LVEF and Vp). The primary
outcome was the incidence of postoperative adverse out-
come, defined as the occurrence of one or more adverse
events. Secondary outcomes consisted of individual adverse
events. Associations between cardiac function and out-
comes were assessed using Pearson chi-squared analysis
with Yates correction. The relationship between systolic
and diastolic function was performed using Spearman cor-
relation. Multivariate logistic regression was performed to
identify the independent factors associated with adverse
outcome. Characteristics that were found to be associated
with an adverse outcome to the P  .25 level were in-
cluded. Both LVEF and Vp were forced into the analyses.
Fig 1. Figure showing normal and abnormal filling pattern of the
left ventricle during diastole. Note the decrease in the slope with
more impaired relaxation. LV, Left ventricle; Vp, Transmitral Flow
Propagation Velocity.Data is presented as mean  standard deviation when
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range [IQR]) when not. Incidences presented as percent-
age of whole or group, and 95% confidence intervals
(95CI) are presented for outcomes, where appropriate.
Statistical significance was determined at the P  .05 level.
SPSS 14.0 (SPSS Inc, Chicago, Ill) was used for analysis.
RESULTS
We completed the study on 325 patients. Twelve pa-
tients were excluded from the study; seven due to severe
aortic stenosis, and five due to severe mitral regurgitation.
The baseline demographics and surgical procedures are
found in Table I. We found 26% (n  80) of patients had
normal left ventricular function, 8% (n  24) isolated
systolic dysfunction, 43% (n  134) isolated diastolic dys-
function, and 24% (n  75) both systolic and diastolic
dysfunction. We found a small but statistically significant
correlation between systolic and diastolic function (P 
.004; r 0.16). By univariate analysis, systolic dysfunction
was associated with a history of CAD, MI, CHF (P .001
for all), and DM (P  .03), but not hypertension or
increasing age. Diastolic dysfunction was only associated
with increasing age (P  .04), but no other demographic
factors.
The most common adverse outcome in our population
Table I. Baseline demographic characteristics of the
study population
Demographic
Age (yr) 71 (62-79)
Gender
F 37% (118)
M 63% (197)
CAD 58% (184)
MI 34% (107)
CABG 20% (63)
HTN 85% (269)
CHF 14% (45)
CVA 10% (33)
DM
Oral 24% (75)
Insulin 28% (88)
RF 14% (44)
EBL (cc) 350 (200-760)
Fluid inputs (cc) 2500 (1800-4900)
LVEF 50% (40%-55%)
Vp (cm/sec) 40 (32-49)
Surgery aortic peripheral 31% (97)
69% (216)
Data presented as median (interquartile range) or percentage of cohort, as
appropriate.
CABG, History of coronary artery bypass surgery; CAD, Coronary artery
disease; CHF,Medical history of congestive heart failure; CVA,History of a
cerebrovascular accident; DM, Diabetes melitis receiving oral therapy in-
cluding either diet or medication for control; EBL, Estimated blood loss
during surgery; fluid inputs: represents intraoperative crystalloid administra-
tion; LVEF, Left ventricular ejection fraction; MI, History of myocardial
infarction; RF, Renal failure; Vp, Mitral valve flow propagation velocity.
Surgery is reported as aortic (abdominal aneurysm or aortic occlusion) or
peripheral (lower extremity revascularization or amputation).was CHF 20% (n  62), followed by arrhythmia 8% (n 26), prolonged intubation 7% (n  22), MI 7% (n  21),
and death 0.6% (n  2). Overall, 30% (n  94) of patients
experienced at least one adverse outcome in the perioper-
ative period. Patients who had any postoperative complica-
tion had significantly longer length of hospital stay (Fig 2);
notably, CHF and prolonged intubation were associated
with longer length of stay (P  .001 for both), but MI,
arrhythmia, and postoperative death were not.
The association between left ventricular function and
adverse outcomes is presented in Table II. We found that
patients who had an abnormal Vp were twice as likely to
have at least one adverse outcome (36% [75] vs. 18% [19];
P  .002) and a significantly longer length of stay (7 days
[range, 5-10 days] vs. 5 days [range, 4-6 days]; P  .001)
compared with subjects with a normal measure. This was
primarily due to an increased incidence of CHF; we found
a statistically significant increase in adverse outcomes with
decreasing Vp (Fig 3). While the incidences of all other
adverse events were greater among patients, these did not
reach statistical significance. In our investigation, EF was
not a significant predictor of any adverse event or increased
length of stay.
As shown in Table III, patients with diastolic dysfunc-
tion, whether isolated or combined with systolic dysfunc-
tion, were more likely to experience adverse events than
patients with either normal cardiac function or isolated
systolic dysfunction. By multivariate logistic regression
(Table IV), we found that several factors were indepen-
dently predictive of postoperative adverse outcome. Nota-
bly, diastolic dysfunction was associated with adverse out-
come, but systolic dysfunction was not.
There were no complications relating to perioperative
TEE use.
DISCUSSION
Our study highlights that the presence of diastolic
dysfunction is an independent predictor of adverse out-
come after major vascular surgery. We found that patients
with diastolic dysfunction, defined as Vp45 cm/sec, had
a significantly increased risk of developing postoperative
adverse outcome and had a longer length of stay. Addition-
ally, in our study diastolic dysfunction was associated with
the postoperative complications most likely to increase a
patient’s length of stay: CHF and prolonged intubation. By
contrast, systolic dysfunction was not associated with ad-
verse outcomes or with increased length of stay. A history of
CHF has previously been shown to be a predictor of
adverse outcome after high-risk vascular surgery.1,3 Xu-Cai
et al22 reported that patients with a history of CHF and
normal systolic function (ie, presumed diastolic dysfunc-
tion) had longer length of stay and higher re-admission rate
after vascular surgery than patients with CHF and abnormal
systolic function and controls. Results of our study agree
with their findings. While the identification of perioperative
diastolic dysfunction using echocardiography during vascu-
lar surgery has previously been reported, an association
with postoperative outcome has not been thoroughly de-
scribed.23,24 The findings of our study suggest that the
ith in
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an important, independent variable in postoperative out-
come, and that further study is warranted.
Diastolic dysfunction is common in the population of
patients undergoing high-risk vascular surgery. In our
study, cohort isolated diastolic dysfunction occurred in 43%
of subjects. Similarly, Phillip et al25 reported that more than
50% of geriatric patients undergoing cardiac and non-
cardiac surgery had preoperative diastolic dysfunction with
Table II. Univariate analysis of adverse outcomes by
patient characteristic
Factor Adverse outcome No complication P-value
Age (yr) 76 (65-81) 69 (60-77) .001
Male gender 27% (52) 36% (42) .12
HTN 30% (75) 34% (15) .66
CAD 32% (59) 28% (35) .49
MI 34% (37) 28% (57) .24
CHF 36% (17) 29% (77) .41
DM 25% (41) 36% (53) .06
RF 42% (19) 28% (75) .08
CVA 44% (15) 28% (79) .09
LVEF (40%) 50 (40-50) 50 (40-55) .35
Vp (45 cm/sec) 43 (34-50) 35 (30-44) .002
Surgery abdominal 49% (46) 23% (51) .001
Data presented as median (interquartile range) or percentage of cohort, as
appropriate. Comparison was performed using Mann-Whitney test or Pear-
son chi-square with Yates correction, as appropriate.
CAD, Coronary artery disease; CHF, Medical history of congestive heart
failure; CVA, History of a cerebrovascular accident; DM, Diabetes melitis
receiving oral therapy including either diet or medication for control; EBL,
Estimated blood loss during surgery; fluid inputs: represents intraoperative
crystalloid administration; LVEF, Left ventricular ejection fraction; MI,
History of myocardial infarction; RF, Renal failure; Vp, Mitral valve flow
propagation velocity.
Surgery is reported as the percentage of abdominal cases (aneurysm or
occlusion).
Fig 2. Increasing length of stay wnormal LVEF. They concluded that a comprehensive leftventricular functional assessment should include evaluation
of both systolic and diastolic function, and our data would
suggest that this is an appropriate approach. If preoperative
assessment were limited to systolic function alone, a signif-
icant proportion of patients with diastolic dysfunction who
are at risk for postoperative adverse events would not be
identified. Whether identification of these patients could
lead changes in care that would result in improved outcome
remains a point of future study. For example, one hypoth-
esis may be that utilizing a care pathway that includes
aggressive fluid restriction and early diuresis might reduce
the incidence of postoperative CHF. This and other strat-
egies remain to be tested, but we believe that our findings
provide evidence that such research is possible.
Diastolic function has not received significant study as a
factor in outcome research possibly due to the absence of a
universal, non-invasive method of classification and diag-
nosis.18,26-35 Traditionally, assessment was based on the
pulse wave Doppler interrogation of the transmitral and
pulmonary venous inflow.34 This method can sometimes
be inconclusive, in part due to the natural history and
progression of relaxation abnormalities (impaired relax-
ation to pseudo-normal to restrictive).26,27,36,37 Further-
more, rapidly changing loading conditions in the operating
room make it more challenging to accurately assess periop-
erative diastolic function with the traditional PWD mea-
sures.23 We chose to assess diastolic function using a more
recently described method: transmitral flow propagation
velocity, or Vp.26,35 Despite limitations, Vp is easily ob-
tained, reproducible, and does not require post-acquisition
manipulation. Also, Vp is a reliable method during periods
of changing loading condition and fluctuating heart
rate.38,39 These features makes it useful for assessment of
perioperative relaxation abnormalities in the OR set-
creased number of complications.ting.40-42
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cardiac function using dipyridamole-Thallium or transtho-
racic echocardiography does not add significant incremen-
tal predictive value of postoperative complications over the
clinical assessment.4,43-46 One possible explanation might
be that these diagnostic tests primarily assess the systolic
function of the left ventricle. We likewise found the assess-
ment of systolic function of the left ventricle to be of lesser
value in predicting immediate adverse events after surgery.
We can identify certain limitations in our study. GA is
known to alter the hemodynamic loading conditions,
which can affect the Doppler filling pattern of the LV. We
chose to use Vp as the single diagnostic criteria for diastolic
Fig 3. Increasing incidence of CHF with decreasing
Propagation Velocity.
Table III. Comparison of adverse events by classification
of left ventricular cardiac function
Cardiac function
Normal
Isolated
systolic
Isolated
diastolic
Combined
systolic/
diastolic
n  80 n  24 n  134 n  75
Adverse
outcome 21% (17) 8% (2) 38% (51)* 32% (24)*
CHF 13% (10) 4% (1) 26% (35)* 21% (16)*
Arrhythmia 6% (5) 0 11% (15) 8% (6)
Prolonged
intubation 5% (4) 0 8% (11) 9% (7)
MI 6% (5) 4% (1) 6% (8) 9% (7)
Death 3% (2) 0 3% (4) 1% (1)
Data presented as percentage of cohort. Comparison between groups was
performed using Mantel-Haenszel statistic.
CHF, Congestive heart failure; MI, Myocardial infarction.
Statistical differences represented as *P  .05.function because it has been known to be less affected byloading conditions and can be reliably used in the operating
room.23 Measurement of Vp has shown excellent repro-
ducibility and intra- and inter-observer reliability.20,21
However, we cannot be certain that our measure of dia-
stolic function taken after the induction of anesthesia
would be comparable to a transthoracic measure taken
prior to surgery. We used subjective assessment of LVEF as
method of quantification of LV systolic function, which has
been shown to be as accurate and reproducible.16,47 Also,
our patient follow-up was limited to the duration of hospi-
tal admission and the effects of diastolic function on the
long-term outcome in our patients are not known.
Although we have demonstrated the predictive value of
perioperative assessment of diastolic function, because of
CHF, Congestive heart failure; Vp, Transmitral Flow
Table IV. Results of multivariate logistic regression
identifying the independent factors associated with
postoperative adverse outcome
Factor P-value Odds ratio 95% CI
*Surgery 0.01 3.4 1.9 6.3
*Age (per 10 yr) 0.01 3.4 1.7 6.5
*Vp 0.01 2.5 1.3 4.6
*RF 0.02 2.6 1.2 5.5
*Female 0.03 1.9 1.1 3.5
CVA 0.07 2.0 0.9 4.8
DM 0.29 1.4 0.7 2.1
LVEF 0.64 1.3 0.7 2.4
*Denotes significant association to the P  .05 level.
CVA, History of a cerebrovascular accident; DM, Diabetes melitis; LVEF,
Abnormal left ventricular ejection fraction; RF, Renal failure; Vp, Mitral
valve flow propagation velocity.
Female gender included vs. male.
Surgery entered as Abdominal (aneurysm or occlusive) vs. Peripheral (lower
extremity revascularization or amputation).Vp.the lack of a specific therapy, the true significance of this
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lusitropic therapy, the mainstay of therapy will likely re-
mains anti-ischemic heart rate control, avoidance of fluid
overload, and diuretic therapy. Establishment of an accu-
rate diagnosis is the first step to develop an effective predic-
tive and therapeutic strategy, and we have demonstrated in
our study that utilizing TEE it is possible to diagnose
diastolic function in the perioperative arena.
In conclusion, the presence of perioperative diastolic
dysfunction, as assessed with Vp, was an independent pre-
dictor of postoperative CHF and prolonged length of stay
after major vascular surgery as compared to patients with-
out diastolic dysfunction. Perioperative systolic function
was not a predictor of postoperative outcome in our pa-
tients. Future studies will be needed to assess the benefits of
inclusion of diastolic function during preoperative risk
stratification, and also goals for treatment.
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